Jingjing Pharmaceutical: Summary table of non-operating fund occupation and other related fund transactions for the first half of 2026
Jingjing Pharmaceutical Group Co., Ltd. 2026 Half Year
Summary table of non-operating fund occupation and other related fund transactions
Unit: 10,000 yuan
Occupiers and listings 2026 half year 2026 half year 2026 half year 2026 half year
Non-operating funds Accounting for listed companies Occupied at the beginning of 2026
Name of the party occupying the funds Cumulative amount of related transactions of the company Cumulative interest repayment of the occupied funds The reason for the occupation of the funds at the end of the period Nature of the occupation Accounting accounts occupied Fund balance
Relation (excluding interest) Interest (if any) Amount Balance
Current controlling shareholder,
Actual controller and non-operating occupation of its affiliated enterprises
Subtotal
former controlling shareholder,
Actual controller and non-operating occupation of its affiliated enterprises
Subtotal
total
2026 half year to 2026 half year 2026 half year 2026 half year
Other related funds Correspondence parties and listed companies Accounting for listed companies Opening transactions in 2026
Name of the counterparty of funds, cumulative amount of current funds, cumulative interest repayment of current funds, reasons for current funds at the end of the period, nature of current transactions, relationship between companies, accounting items, fund balance
(Excluding interest) Interest (if any) Amount Balance
Nantong Asset Management has
Controlled by the controlling shareholder Accounts receivable 1.15 0.40 0.75 Sales payment Operating transactions Co., Ltd.
Nantong Jiangtian Chemical Stock Accounts receivable 31.60 31.60
The controlling shareholder controls the sales payment and operating transactions Co., Ltd.
Receivables financing 31.60 31.60
Nantong Yangzi Carbon Co., Ltd.’s controlling shareholder
Controlling shareholder, actual accounts receivable 0.16 0.16 Sales payment Operating transactions
Co., Ltd. has significant influence
international controller and its
Affiliated enterprise Nantong Jiangdong Carbon Co., Ltd.’s controlling shareholder
Accounts receivable 0.16 0.16 Sales payment For-profit trading company has significant impact
The controlling shareholder of Nantong Jiangshan Pesticide Chemical Co., Ltd.
Accounts receivable 8.72 8.72 Sales payment For-profit Correspondent Co., Ltd. has a significant impact
Jin Tongling Technology Group
Controlled by the controlling shareholder Accounts receivable 1.42 1.42 0.00 Sales payment Operating transactions Co., Ltd.
Subtotal 31.60 43.21 0.00 33.42 41.39
Essence of traditional Chinese medicine (Southern
Controlled subsidiaries Accounts receivable 8.79 10.46 12.00 7.25 Sales payment Operating Current Co., Ltd.
Nantong Jidesheng Technology
Controlled subsidiaries Accounts receivable 9.47 0.68 10.15 Sales payments Operating transactions
Ltd.
2026 half year to 2026 half year 2026 half year 2026 half year
Other related funds Correspondence parties and listed companies Accounting for listed companies Opening transactions in 2026
Name of the counterparty of funds, cumulative amount of current funds, cumulative interest repayment of current funds, reasons for current funds at the end of the period, nature of current transactions, relationship between companies, accounting items, fund balance
(Excluding interest) Interest (if any) Amount Balance
Baohe Hall (Bozhou)
Controlled subsidiaries Other receivables 63,970.30 1,000.00 1,000.00 63,970.30 Entrusted loans and interest Non-operating current Pharmaceutical Co., Ltd.
Baohe Hall (Bozhou)
Controlled subsidiaries Other receivables 6.76 6.76 0.00 in advance of social security provident fund Non-operating current Pharmaceutical Co., Ltd.
Jiangsu Senxuan Pharmaceutical Stocks
Controlled subsidiaries Other receivables 87.35 87.35 0.00 Rent, etc. Operating Current Co., Ltd.
Subsidiary of listed company Jiangsu Senxuan Pharmaceutical Stock
Controlled subsidiaries Other receivables 8.21 8.21 0.00 Advances to social security provident funds Non-operating current companies and their subsidiaries
Enterprise Jingjing Sinopharm (South
Controlled subsidiaries Other receivables 0.35 0.35 0.00 Advances to provident funds, etc. Non-operating (Non-operating) Co., Ltd.
Jingjing Pharmaceutical Group South
Controlled subsidiaries Other receivables 519.19 519.19 0.00 Advance salary and other expenses Non-operating WeChat Co., Ltd.
Longxi Baohetang Pharmaceutical
Controlled subsidiaries Other receivables 11,640.42 150.83 200.00 11,591.25 Entrusted loans and interest Non-operating current limited liability company
Longxi Baohetang Pharmaceutical
Controlled subsidiaries Other receivables 14.71 14.71 0.00 in advance of social security provident fund Non-operating current limited liability company
Baohe Hall (Bozhou)
Controlled subsidiaries Prepaid accounts 630.93 758.93 938.36 451.50 Procurement Operating transactions Pharmaceutical Co., Ltd.
Subtotal 76,259.91 2,557.47 0.00 2,786.93 76,030.45
Total 76,291.51 2,600.68 0.00 2,820.35 76,071.84